| Log in

For us, M&As are about calibrated aggression: Ramesh Swaminathan, CFO of Lupin

23 June, 2014

Mumbai-based Lupin Ltd is the second-largest pharma company in the country by market capitalisation behind Sun Pharma. It is dominant in the anti-TB and cephalosporin segment but i ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Lupin CFO Ramesh Swaminathan on growth strategy and new geographies it plans to enter

Lupin CFO Ramesh Swaminathan on growth strategy and new geographies it plans to enter

VCC Staff 3 years ago
Lupin is the second-largest pharma company in the country by market...
Lupin eyes acquisitions of up to $1B to expand overseas

Lupin eyes acquisitions of up to $1B to expand overseas

Jasleen Kaur Batra 3 years ago
Mumbai-based pharma major Lupin Ltd, seen as a conservative drugmaker compared...
Lupin to buy remaining 40% stake in South African generic drugmaker Pharma Dynamics

Lupin to buy remaining 40% stake in South African generic drugmaker Pharma Dynamics

Jasleen Kaur Batra 3 years ago
Mumbai-based pharma major Lupin Ltd has entered into an agreement to acquire the...
No Comments

For us, M&As are about calibrated aggression: Ramesh Swaminathan, CFO of Lupin

Powered by WordPress.com VIP